BRCA1 mutation in the Triple- Negative Breast Cancer Group

被引：0
|
作者：
Jelena Maksimenko
Arvids Irmejs
Genadijs Trofimovics
Edvins Miklasevics
机构：
[1] Riga Stradins University,The Institute of Oncology
来源：
Hereditary Cancer in Clinical Practice | / 10卷 / Suppl 4期
关键词：
Breast Cancer; BRCA1 Mutation; Breast Cancer Subtype; BRCA1 Mutation Carrier; Founder Mutation;
D O I：
10.1186/1897-4287-10-S4-A15
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer
    Comen, E. A.
    Davids, M.
    Kirchhoff, T.
    Balistreri, L.
    Hansen, J.
    Kosarin, K.
    Offit, K.
    Robson, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] A de novo BRCA1 gene mutation in a 29-year-old woman with triple negative breast cancer
    Gebhart, Paulina
    Tan, Yen
    Muhr, Daniela
    Stein, Christina
    Singer, Christian F.
    BREAST CARE, 2023, 18 (05) : 412 - 416
  • [23] Triple Negative Breast Cancer in BRCA1 Mutation Carriers With a Complete Radiologic Response to Neoadjuvant Paclitaxel: A Case Report
    Burness, Monika L.
    Obeid, Elias I.
    Olopade, Olufunmilayo I.
    CLINICAL BREAST CANCER, 2015, 15 (02) : E155 - E158
  • [24] Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort
    Liu, Xiaoran
    Li, Huiping
    Shao, Bin
    Wu, Jianmin
    Kong, Weiyao
    Song, Guohong
    Jiang, Hanfang
    Wang, Jing
    Wan, Fengling
    CANCER MEDICINE, 2017, 6 (03): : 547 - 554
  • [25] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1382 - 1384
  • [26] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Glodzik, Dominik
    Bosch, Ana
    Hartman, Johan
    Aine, Mattias
    Vallon-Christersson, Johan
    Reutersward, Christel
    Karlsson, Anna
    Mitra, Shamik
    Nimeus, Emma
    Holm, Karolina
    Hakkinen, Jari
    Hegardt, Cecilia
    Saal, Lao H.
    Larsson, Christer
    Malmberg, Martin
    Ryden, Lisa
    Ehinger, Anna
    Loman, Niklas
    Kvist, Anders
    Ehrencrona, Hans
    Nik-Zainal, Serena
    Borg, Ake
    Staaf, Johan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [27] BRCA1/2 mutation prevalence in triple-negative breast cancer patients without family history of breast and ovarian cancer.
    Rhiem, Kerstin
    Engel, Christoph
    Engel, Jutta
    Niederacher, Dieter
    Sutter, Christian
    Varon-Mateeva, Raymonda
    Steinemann, Doris
    Arnold, Norbert
    Dworniczak, Bernd
    Wang-Gohrke, Shan
    Gehrig, Andrea
    Wappenschmidt, Barbara
    Meindl, Alfons
    Schmutzler, Rita K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Dominik Glodzik
    Ana Bosch
    Johan Hartman
    Mattias Aine
    Johan Vallon-Christersson
    Christel Reuterswärd
    Anna Karlsson
    Shamik Mitra
    Emma Niméus
    Karolina Holm
    Jari Häkkinen
    Cecilia Hegardt
    Lao H. Saal
    Christer Larsson
    Martin Malmberg
    Lisa Rydén
    Anna Ehinger
    Niklas Loman
    Anders Kvist
    Hans Ehrencrona
    Serena Nik-Zainal
    Åke Borg
    Johan Staaf
    Nature Communications, 11
  • [29] Expression of Id4, a BRCA1 Downregulator, in Triple Negative Breast Cancer
    Wen, Y. H.
    Akram, M.
    Nehhozina, T.
    Bowser, Z.
    Norton, L.
    Brogi, E.
    LABORATORY INVESTIGATION, 2010, 90 : 77A - 78A
  • [30] BRCA1 methylation contributes to the triple-negative breast cancer phenotype.
    Nwachukwu, C.
    Grushko, T. A.
    Xu, J.
    Khramtsov, A.
    Olopade, O., I
    CANCER RESEARCH, 2009, 69 (02) : 266S - 266S
12345